In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Frank Ruschitzka
Speaker
Frank Ruschitzka
Frank Ruschitzka Frank Ruschitzka

University Heart Center, Zurich (Switzerland)

Specialities : Acute Heart Failure , Chronic Heart Failure, Device Therapy

Professor Frank Ruschitzka, MD, FRCP (Edinburgh), FESC is Chairman of the University Heart Center and the Department of Cardiology at the University Hospital in Zürich, Switzerland. Professor Ruschitzka received his medical degree in 1989 and has specialized in internal medicine and cardiology at the Universities of Göttingen and Zürich. Professor Ruschitzka received numerous awards, including the Cardiovascular Science Award of the Swiss Society of Cardiology, the annual Götz-Preis of the Medical Faculty of the University of Zürich for excellence in clinical medicine and research as well as the Honoris Causa Doctorate of the University of Medicine “Carol Davila” Bucharest. Professor Ruschitzka is Past-President of the Heart Failure Association of the ESC and deputy editor of the European Heart Journal. Professor Ruschitzka`s research focuses on the development of novel drugs, devices and interventions, in coronary artery disease and heart failure in particular.

99 presentations from this speaker

Classification of heart failure by ejection fraction should be maintained - CON.

Event : ESC Congress 2020

  • Session : Controversies in Heart Failure: Classification by Ejection Fraction Should Be Maintained
  • Speaker : F Ruschitzka (Zurich,CH)

Daily Wrap Up Monday.

Event : ESC Congress 2020

  • Session : Daily Wrap-Up Monday
  • Speaker : G Hindricks (Leipzig,DE), DE Grobbee (Utrecht,NL), F Ruschitzka (Zurich,CH)

Hot Line DAPA-CKD.

Event : ESC Congress 2020

  • Session : Hot Line DAPA-CKD
  • Speaker : R Collins (Oxford,GB), F Ruschitzka (Zurich,CH), J L Heerspink (Groningen,NL), DE Grobbee (Utrecht,NL)

Hot Line PARALLAX.

Event : ESC Congress 2020

  • Session : Hot Line PARALLAX
  • Speaker : BJ Mulder (Amsterdam,NL), F Ruschitzka (Zurich,CH), B Pieske (Berlin,DE), R De Boer (Groningen,NL)

A novel approach to atrial fibrillation: the HFA algorithm.

Event : Heart Failure 2019

  • Session : Atrial fibrillation and heart failure
  • Speaker : F Ruschitzka (Zurich,CH)
  • Joint Session with the European Heart Rhythm Association (EHRA)

Conclusion and take home message.

Event : Heart Failure 2019

  • Session : The Grand Debate 2: Challenges in heart failure management: mitral regurgitation and atrial fibrillation
  • Speaker : F Ruschitzka (Zurich,CH)

Devices and interventions.

Event : Heart Failure 2019

  • Session : Heart Failure 2019 Highlights
  • Speaker : F Ruschitzka (Zurich,CH)

Machine learning-based phenogrouping in heart failure

Event : ESC Congress 2019

  • Session : The future of precision medicine: the case of cardiology
  • Speaker : F Ruschitzka (Zurich,CH), M Cikes (Zagreb,HR)

Panel discussion - Making critical choices for patients at the right time.

Event : Heart Failure 2019

  • Session : Making critical choices for patients at the right time – Join the discussion
  • Speaker : F Ruschitzka (Zurich,CH), JJV McMurray (Glasgow,GB), M Senni (Bergamo,IT), J Butler (Atlanta,US)
  • Sponsored by Novartis

Panel discussion - Treatment choices to optimise benefits for heart failure patients.

Event : Heart Failure 2019

  • Session : Treatment choices to optimise benefits for heart failure patients
  • Speaker : F Ruschitzka (Zurich,CH), JJV McMurray (Glasgow,GB), M Senni (Bergamo,IT), J Butler (Atlanta,US)
  • Sponsored by Novartis

Percutaneous mitral valve interventions in heart failure: Mitra-HF, COAPT and beyond

Event : ESC Congress 2019

  • Session : Interventional therapy for heart failure
  • Speaker : F Ruschitzka (Zurich,CH)

Positioning of the topic.

Event : Heart Failure 2019

  • Session : The Grand Debate 2: Challenges in heart failure management: mitral regurgitation and atrial fibrillation
  • Speaker : F Ruschitzka (Zurich,CH)

Questions and answers

Event : ESC Congress 2019

  • Session : Spotlight on the effects of SGLT2 inhibition in heart failure (EBAC accredited)
  • Speaker : F Ruschitzka (Zurich,CH), M Bonaca (Boston,US), S Verma (Toronto,CA), M Kosiborod (Kansas,US)
  • Supported by an unrestricted educational grant from AstraZeneca

Summary and close - Know it by heart – New opportunities for cardiologists in the SGLT2 inhibitor era.

Event : Heart Failure 2019

  • Session : Know it by heart – New opportunities for cardiologists in the Sodium-Glucose-Co-Transporter 2 (SGLT2) inhibitor era
  • Speaker : F Ruschitzka (Zurich,CH), F Zannad (Vandoeuvre,FR)
  • Sponsored by Boehringer Ingelheim & Eli Lilly and Company Alliance

The hidden burden of heart failure

Event : ESC Congress 2019

  • Session : Spotlight on the effects of SGLT2 inhibition in heart failure (EBAC accredited)
  • Speaker : F Ruschitzka (Zurich,CH)
  • Supported by an unrestricted educational grant from AstraZeneca

Therapeutic synergy between drugs, devices and interventions.

Event : Heart Failure 2019

  • Session : Functional mitral regurgitation: the road ahead.
  • Speaker : F Ruschitzka (Zurich,CH)

Welcome and introduction - Know it by heart – New opportunities for cardiologists in the SGLT2 inhibitor era.

Event : Heart Failure 2019

  • Session : Know it by heart – New opportunities for cardiologists in the Sodium-Glucose-Co-Transporter 2 (SGLT2) inhibitor era
  • Speaker : F Ruschitzka (Zurich,CH)
  • Sponsored by Boehringer Ingelheim & Eli Lilly and Company Alliance

Welcome and introduction - Treatment choices to optimise benefits for heart failure patients.

Event : Heart Failure 2019

  • Session : Treatment choices to optimise benefits for heart failure patients
  • Speaker : F Ruschitzka (Zurich,CH)
  • Sponsored by Novartis

Case 2 - I don't need to escalate therapy when my HFrEF patients are stable!

Event : ESC Congress 2018

  • Session : Therapeutic dilemmas in heart failure : debate of the experts
  • Speaker : F Ruschitzka (Zurich,CH), M Jessup (Hingham,US), B Pieske (Berlin,DE)
  • Organised by Medscape Education, supported with an educational grant from Novartis

Clinical Trial Update - Let's discuss CABANA

Event : Heart Failure 2018

  • Session : Clinical Trial Update - Let's discuss CABANA
  • Speaker : F Ruschitzka (Zurich,CH), G Hindricks (Leipzig,DE)

Closing remarks

Event : Heart Failure 2018

  • Session : Inaugural Session
  • Speaker : F Ruschitzka (Zurich,CH)

Conclusion and take home message

Event : Heart Failure 2018

  • Session : GRAND DEBATE I - Drugs or interventions - The beat goes on
  • Speaker : F Ruschitzka (Zurich,CH)

Dilemmas in heart failure management: what do the experts say?

Event : ESC Congress 2018

  • Session : Dilemmas in heart failure management: what do the experts say?
  • Speaker : CS Lam (Singapore,SG), B Pieske (Berlin,DE), S Solomon (Boston,US), F Ruschitzka (Zurich,CH), M Jessup (Hingham,US)
  • Organised by Medscape Education, supported with an educational grant by Novartis

Drug treatment of chronic heart failure

Event : ESC Congress 2018

  • Session : Heart failure: review, update, and State of the Art in 2018 - Part 1 (Diagnosis and drug treatment)
  • Speaker : F Ruschitzka (Zurich,CH)

Is there a role for anti-arrhythmic drugs or catheter ablation?

Event : EHRA 2018

  • Session : New insights on atrial fibrillation in patients with HFrEF and HFpEF: treatment strategies to optimise outcome
  • Speaker : F Ruschitzka (Zurich,CH)
  • Joint session with the Heart Failure Association of the ESC (HFA)

Key takeaways - Closing.

Event : Heart Failure 2018

  • Session : PURE-HF and the future of decongestive therapies
  • Speaker : F Ruschitzka (Zurich,CH)
  • Sponsored by Fresenius Medical Care

Panel discussion and audience Q&A.

Event : Heart Failure 2018

  • Session : Resolving dilemmas in the treatment of heart failure
  • Speaker : F Ruschitzka (Zurich,CH)
  • Sponsored by Novartis

Positioning of the topic

Event : Heart Failure 2018

  • Session : GRAND DEBATE I - Drugs or interventions - The beat goes on
  • Speaker : F Ruschitzka (Zurich,CH)

President’s Report.

Event : Heart Failure 2018

  • Session : HFA General Assembly
  • Speaker : F Ruschitzka (Zurich,CH)

Putting it all together.

Event : Heart Failure 2018

  • Session : PURE-HF and the future of decongestive therapies
  • Speaker : F Ruschitzka (Zurich,CH)
  • Sponsored by Fresenius Medical Care

Seize the moment to optimize heart failure treatment: why, when, and how? Ask the experts.

Event : ESC Congress 2018

  • Session : Seize the moment to optimize heart failure treatment: why, when, and how? Ask the experts
  • Speaker : F Ruschitzka (Zurich,CH), JJV McMurray (Glasgow,GB), R Wachter (Leipzig,DE), S Solomon (Boston,US)
  • Sponsored by Novartis Pharma AG.

Session evaluation and key learnings.

Event : ESC Congress 2018

  • Session : Advances and investigational devices in heart failure
  • Speaker : F Ruschitzka (Zurich,CH)
  • Sponsored by Medtronic

Session objectives.

Event : ESC Congress 2018

  • Session : Advances and investigational devices in heart failure
  • Speaker : F Ruschitzka (Zurich,CH)
  • Sponsored by Medtronic

Survivors of a myocardial infarction with low left ventricular ejection fraction - Do we know what we need to know?

Event : EHRA 2018

  • Session : 20 years after MADIT - Who is at risk of sudden death?
  • Speaker : F Ruschitzka (Zurich,CH)

Treatment of atrial fibrillation in heart failure: the road ahead

Event : ESC Congress 2018

  • Session : Atrial fibrillation in heart failure
  • Speaker : F Ruschitzka (Zurich,CH)

Welcome & Introduction.

Event : Heart Failure 2018

  • Session : HFA General Assembly
  • Speaker : F Ruschitzka (Zurich,CH)

Welcome and introduction.

Event : Heart Failure 2018

  • Session : PURE-HF and the future of decongestive therapies
  • Speaker : F Ruschitzka (Zurich,CH)
  • Sponsored by Fresenius Medical Care

Welcome and introduction.

Event : Heart Failure 2018

  • Session : Resolving dilemmas in the treatment of heart failure
  • Speaker : F Ruschitzka (Zurich,CH)
  • Sponsored by Novartis

Welcome to Heart Failure 2018.

Event : Heart Failure 2018

  • Session : Inaugural Session
  • Speaker : F Ruschitzka (Zurich,CH)

Atrial fibrillation ablation is rarely needed in heart failure - CONTRA.

Event : EHRA 2017

  • Session : Controversies in ablation therapy: asymptomatic atrial fibrillation and atrial fibrillation in heart failure
  • Speaker : F Ruschitzka (Zurich,CH)

Atrial fibrillation: electrical phenomenon or left atrial disease?

Event : ESC Congress 2017

  • Session : Atrial fibrillation or left atrial disease?
  • Speaker : F Ruschitzka (Zurich,CH)

Chairperson Concluding Question

Event : ESC Congress 2017

  • Session : Are vasodilators useful in the treatment of acute heart failure?
  • Speaker : F Ruschitzka (Zurich,CH)

Chronic pain – Selective COX-2 inhibitor or NSAID?

Event : Heart Failure 2017

  • Session : Comorbidities: prequel or sequel to heart failure
  • Speaker : F Ruschitzka (Zurich,CH)

Grand finale.

Event : Heart Failure 2017

  • Session : Implantable Cardioverter Defibrillator (ICD)
  • Speaker : F Ruschitzka (Zurich,CH)

How should we treat FMR in the future? Discussion.

Event : Heart Failure 2017

  • Session : Treating Functional Mitral Regurgitation (FMR) in heart failure with Transcatheter Mitral Valve Repair (TMVR): rendez-vous with the future now!
  • Speaker : F Ruschitzka (Zurich,CH), E Donal (Rennes,FR), J Seeburger (Leipzig,DE), C Grasso (Catania,IT), A Vahanian (Vincennes,FR)
  • Sponsored by ABBOTT STRUCTURAL HEART

Introduction.

Event : Heart Failure 2017

  • Session : Treating Functional Mitral Regurgitation (FMR) in heart failure with Transcatheter Mitral Valve Repair (TMVR): rendez-vous with the future now!
  • Speaker : F Ruschitzka (Zurich,CH), A Vahanian (Vincennes,FR)
  • Sponsored by ABBOTT STRUCTURAL HEART

Key takeaways (closing).

Event : Heart Failure 2017

  • Session : Understanding congestion: thinking beyond diuretic therapy
  • Speaker : F Ruschitzka (Zurich,CH)
  • Sponsored by Fresenius Medical Care

Optimising contemporary heart failure with reduced ejection fraction therapies in patients with comorbidities – Clinical case discussion.

Event : Heart Failure 2017

  • Session : Contemporary management of patients with Heart Failure with reduced Ejection Fraction (HFrEF)
  • Speaker : F Ruschitzka (Zurich,CH)
  • Sponsored by Novartis

Optimising treatment of heart failure – Where are we today?

Event : Heart Failure 2017

  • Session : Optimising treatment of heart failure – Where are we today?
  • Speaker : F Ruschitzka (Zurich,CH), JR Teerlink (San Francisco,US), JJV McMurray (Glasgow,GB)
  • Sponsored by Novartis

Panel discussion - Managing heart failure in 2017.

Event : ESC Congress 2017

  • Session : Managing heart failure in 2017: the experts’ opinion
  • Speaker : M Komajda (Paris,FR), JJV McMurray (Glasgow,GB), D Atar (Oslo,NO), F Ruschitzka (Zurich,CH)
  • Organised by Medscape Education, supported with an educational grant by Novartis

Panel discussion and close - Hyperkalaemia and iron deficiency: how too much or too little may affect the heart.

Event : ESC Congress 2017

  • Session : Hyperkalaemia and iron deficiency: how too much or too little may affect the heart
  • Speaker : J Comin-Colet (Hospitalet De Llobregat,ES), F Ruschitzka (Zurich,CH)
  • Sponsored by Vifor Pharma

Panel discussion and Q&A.

Event : Heart Failure 2017

  • Session : Understanding congestion: thinking beyond diuretic therapy
  • Speaker : F Ruschitzka (Zurich,CH), G Filippatos (Athens,GR)
  • Sponsored by Fresenius Medical Care

Patients with non-ischaemic heart failure should receive an ICD - Introduction.

Event : Heart Failure 2017

  • Session : Implantable Cardioverter Defibrillator (ICD)
  • Speaker : F Ruschitzka (Zurich,CH)

President's Report .

Event : Heart Failure 2017

  • Session : HFA General Assembly
  • Speaker : F Ruschitzka (Zurich,CH)

The European Heart Journal's Year in Cardiology: heart failure and valvular heart disease - Conclusion.

Event : ESC Congress 2017

  • Session : The European Heart Journal's Year in Cardiology: heart failure and valvular heart disease
  • Speaker : F Ruschitzka (Zurich,CH)
  • Joint with the European Heart Journal

Welcome & introduction.

Event : Heart Failure 2017

  • Session : Understanding congestion: thinking beyond diuretic therapy
  • Speaker : F Ruschitzka (Zurich,CH), G Filippatos (Athens,GR)
  • Sponsored by Fresenius Medical Care

Welcome from the President of the HFA.

Event : Heart Failure 2017

  • Session : Inaugural Session
  • Speaker : F Ruschitzka (Zurich,CH)

What do the guidelines recommend?

Event : ESC Congress 2017

  • Session : On the cutting edge of heart failure management: 2017
  • Speaker : F Ruschitzka (Zurich,CH)
  • Organised by Medscape Education, supported with an educational grant by Novartis

Acute heart failure - Can we win the battle or the war? Part 2

Event : ESC Congress 2016

  • Session : What does the busy cardiologist need to know about recent advances in cardiology?
  • Speaker : F Ruschitzka (Zurich,CH)

Ask the experts: your questions on optimizing heart failure management and the future of new treatments answered.

Event : Heart Failure 2016

  • Session : Ask the experts: your questions on optimizing heart failure management and the future of new treatments answered
  • Speaker : JJV McMurray (Glasgow,GB), B Pieske (Berlin,DE), F Ruschitzka (Zurich,CH), M Senni (Bergamo,IT)
  • Sponsored by Novartis Pharma AG

Atrial fibrillation or left atrial disease?

Event : Heart Failure 2016

  • Session : Management of atrial fibrillation in heart failure
  • Speaker : F Ruschitzka (Zurich,CH)

Benefits of a multidisciplinary approach when optimizing current and integrating new heart failure treatments for improved outcomes: panel discussion.

Event : Heart Failure 2016

  • Session : Optimizing current and integrating new treatments to improve outcomes in heart failure: practical insights
  • Speaker : F Ruschitzka (Zurich,CH), R Hobbs (Oxford,GB), T Jaarsma (Norrkoping,SE), J Riley (London,GB), B Pieske (Berlin,DE), M Senni (Bergamo,IT)
  • Sponsored by Novartis Pharma AG

Heart failure and cardiomyopathies

Event : ESC Congress 2016

  • Session : ESC Congress Highlights
  • Speaker : F Ruschitzka (Zurich,CH)

Heart team panel live on stage and discussion

Event : ESC Congress 2016

  • Session : RBBB and heart failure. Is CRT the answer? Heart team discussion
  • Speaker : M Castillo (Madrid,ES), C Fernandez-Golfin (Madrid,ES), E Franco (Madrid,ES), D Rodriguez Munoz (Madrid,ES), F Ruschitzka (Zurich,CH)

Henry's legacy.

Event : Heart Failure 2016

  • Session : A tribute to Henry Krum
  • Speaker : F Ruschitzka (Zurich,CH)

HFA Board 2016-2018.

Event : Heart Failure 2016

  • Session : HFA General Assembly
  • Speaker : F Ruschitzka (Zurich,CH)

Introduction.

Event : Heart Failure 2016

  • Session : Treating mitral regurgitation in heart failure patients: does transcatheter mitral valve repair improve living?
  • Speaker : F Ruschitzka (Zurich,CH)
  • Sponsored by Abbott Vascular

Management of chronic heart failure: devices and interventions.

Event : Heart Failure 2016

  • Session : The new ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure - Overview
  • Speaker : F Ruschitzka (Zurich,CH)

New therapies for chronic heart failure: case study approach to using the guidelines.

Event : ESC Congress 2016

  • Session : European guidelines update: putting key recommendations into practice for chronic heart failure
  • Speaker : F Ruschitzka (Zurich,CH)
  • Sponsored by Medscape

Panel discussion - European guidelines update: putting key recommendations into practice for chronic heart failure.

Event : ESC Congress 2016

  • Session : European guidelines update: putting key recommendations into practice for chronic heart failure
  • Speaker : AP Maggioni (Milano,IT), F Ruschitzka (Zurich,CH), A Voors (Groningen,NL), C Yancy (Chicago,US)
  • Sponsored by Medscape

Summary of key learning points and close.

Event : Heart Failure 2016

  • Session : Optimizing current and integrating new treatments to improve outcomes in heart failure: practical insights
  • Speaker : F Ruschitzka (Zurich,CH), M Senni (Bergamo,IT)
  • Sponsored by Novartis Pharma AG

Take home message.

Event : Heart Failure 2016

  • Session : Treating mitral regurgitation in heart failure patients: does transcatheter mitral valve repair improve living?
  • Speaker : F Ruschitzka (Zurich,CH)
  • Sponsored by Abbott Vascular

The European Heart Journal's Year in Cardiology: heart failure and valvular heart disease - Conclusion

Event : ESC Congress 2016

  • Session : The European Heart Journal's Year in Cardiology: heart failure and valvular heart disease
  • Speaker : F Ruschitzka (Zurich,CH)
  • Joint with the European Heart Journal

The HFA Eugene Braunwald lecture: introduction of Karl Swedberg.

Event : Heart Failure 2016

  • Session : Inaugural Session
  • Speaker : F Ruschitzka (Zurich,CH)

Welcome and introduction.

Event : Heart Failure 2016

  • Session : Optimizing current and integrating new treatments to improve outcomes in heart failure: practical insights
  • Speaker : F Ruschitzka (Zurich,CH), M Senni (Bergamo,IT)
  • Sponsored by Novartis Pharma AG

Devices for heart failure.

Event : ESC Congress 2015

  • Session : The ESC/HFA Guidelines on acute and chronic heart failure
  • Speaker : F Ruschitzka (Zurich,CH)

Heart failure and cardiomyopathies.

Event : ESC Congress 2015

  • Session : ESC Congress Highlights
  • Speaker : F Ruschitzka (Zurich,CH)

HFA Lifetime Achievement Awards: Eugene Braunwald and Henry Dargie.

Event : Heart Failure 2015

  • Session : Inaugural Session
  • Speaker : F Ruschitzka (Zurich,CH), G Filippatos (Athens,GR)

ICD is superfluous in responders to CRT- Contra.

Event : EHRA 2015

  • Session : Devices may not be forever? Can ongoing ICD or CRT therapy become unnecessary?
  • Speaker : F Ruschitzka (Zurich,CH)

ICD is superfluous in responders to CRT- Rebuttal Contra.

Event : EHRA 2015

  • Session : Devices may not be forever? Can ongoing ICD or CRT therapy become unnecessary?
  • Speaker : F Ruschitzka (Zurich,CH)

Introduction.

Event : Heart Failure 2015

  • Session : Preventing sudden cardiac death in the newly diagnosed heart failure patient
  • Speaker : F Ruschitzka (Zurich,CH)
  • Sponsored by Zoll

Introduction.

Event : Heart Failure 2015

  • Session : Treating mitral regurgitation in heart failure patients: why Transcatheter Mitral Valve Repair (TMVR) and multidisciplinary care are key
  • Speaker : F Ruschitzka (Zurich,CH)
  • Sponsored by Abbott Vascular

Panel discussion – Sleep disordered breathing in Heart Failure (HF), SERVE HF results and beyond.

Event : ESC Congress 2015

  • Session : Sleep disordered breathing in Heart Failure (HF), SERVE HF results and beyond
  • Speaker : M Cowie (London,GB), K Wegscheider (Hamburg,DE), H Woehrle (Ulm,DE), CS Lam (Singapore,SG), F Ruschitzka (Zurich,CH), M Metra (Brescia,IT)
  • Sponsored by ResMed

PRomPT: Discussant review.

Event : ESC Congress 2015

  • Session : Hot Line I - Acute myocardial infarction
  • Speaker : F Ruschitzka (Zurich,CH)

Summary.

Event : ESC Congress 2015

  • Session : The European Heart Journal's year in cardiology: heart failure and valvular heart disease
  • Speaker : F Ruschitzka (Zurich,CH)

Take home messages.

Event : Heart Failure 2015

  • Session : Treating mitral regurgitation in heart failure patients: why Transcatheter Mitral Valve Repair (TMVR) and multidisciplinary care are key
  • Speaker : F Ruschitzka (Zurich,CH)
  • Sponsored by Abbott Vascular

Welcome from the scientific chairpersons.

Event : Heart Failure 2015

  • Session : Inaugural Session
  • Speaker : F Ruschitzka (Zurich,CH), M Crespo-Leiro (La Coruna,ES)

Introduction - New onset heart failure patients are different - A strategy for managing SCD risk during medical optimization.

Event : ESC Congress 2014

  • Session : New onset heart failure patients are different - A strategy for managing sudden cardiac death (SCD) risk during medical optimization
  • Speaker : F Ruschitzka (Zurich,CH), D Thomas (Heidelberg,DE)
  • Sponsored by Zoll

Panel discussion with Q&A - Improving outcomes for heart failure patients.

Event : ESC Congress 2014

  • Session : Improving outcomes for heart failure patients
  • Speaker : F Ruschitzka (Zurich,CH)
  • Sponsored by St Jude Medical

Summary.

Event : ESC Congress 2014

  • Session : The European Heart Journal’s Year in Cardiology: heart failure and valvular heart disease
  • Speaker : F Ruschitzka (Zurich,CH)

Ventricular assist devices: for whom, when and which device.

Event : ESC Congress 2014

  • Session : Challenges in the management of advanced heart failure
  • Speaker : F Ruschitzka (Zurich,CH)

Challenges in the treatment of hypertension - Take home message & what do the guidelines say?

Event : ESC Congress 2013

  • Session : Challenges in the treatment of hypertension
  • Speaker : F Ruschitzka (Zurich,CH)

Heart failure with narrow QRS complex.

Event : ESC Congress 2013

  • Session : Evolving indications of cardiac resynchronisation therapy
  • Speaker : F Ruschitzka (Zurich,CH)

Heart failure.

Event : ESC Congress 2013

  • Session : Hypertension and the heart
  • Speaker : F Ruschitzka (Zurich,CH)

Swiss centre.

Event : ESC Congress 2013

  • Session : ESC Cardiology Quiz
  • Speaker : TF Luscher (London,GB), F Ruschitzka (Zurich,CH), M Greutmann (Zurich,CH), FC Tanner (Zurich,CH), O Gaemperli (Zurich,CH), J Steffel (Meilen,CH)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are